Dr. Sreelakshmi Kooragayalu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-1200 |
Venumadhav Chirunomula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Hospitalist Department, Cumberland, MD 21502 Phone: 240-964-8564 |
William Davidson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-8720 |
News Archive
Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.
Trillium Therapeutics Inc. , a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into a definitive license agreement with Biogen Idec , granting the latter exclusive worldwide rights to one of Trillium's development programs.
The U.N. General Assembly opened its 65th session on Tuesday in New York with the incoming Assembly President Joseph Deiss, former Swiss foreign minister, calling for the focus of the upcoming year to be prioritizing efforts to achieve the U.N. Millennium Development Goals (MDGs), reaffirming the role of the U.N. in global governance and promoting sustainable development, Xinhua reports (9/15).
Women who have been infected by two different strains of HIV from two different sexual partners - a condition known as HIV superinfection - have more potent antibody responses that block the replication of the virus compared to women who've only been infected once. These findings, by researchers at Fred Hutchinson Cancer Research Center in Seattle, are published online March 29 in PLoS Pathogens.
The World Bank vice president, Jim Adams, says that officials from all over the world will meet in Geneva in early November to discuss setting up a global fund to tackle the threat of the deadly H5N1 avian flu virus.
› Verified 8 days ago